Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products workshop summary

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process i...

Descripción completa

Detalles Bibliográficos
Autor principal: Caruso, Denise, 1956- (-)
Autores Corporativos: Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation (-), Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products (Workshop)
Otros Autores: English, Rebecca A., Claiborne, Anne B.
Formato: Libro electrónico
Idioma:Inglés
Publicado: Washington, D.C. : National Academies Press [2014]
Colección:National Academies ebooks.
Acceso en línea:Conectar con la versión electrónica
Ver en Universidad de Navarra:https://innopac.unav.es/record=b44940944*spi